Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture.
Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

Pharmaceuticals

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

SALICIN CRS (50 MG)

SALICIN CRS (50 MG)

138-52-3

DISCOVER
NONIVAMIDE CRS (20 MG)

NONIVAMIDE CRS (20 MG)

2444-46-4

DISCOVER
CAPSAICIN CRS (50 MG)

CAPSAICIN CRS (50 MG)

404-86-4

DISCOVER
IOHEXOL FOR PEAK IDENTIFICATION CRS (10 MG)

IOHEXOL FOR PEAK IDENTIFICATION CRS (10 MG)

66108-95-0

DISCOVER
HARPAGOSIDE CRS (1 MG)

HARPAGOSIDE CRS (1 MG)

19210-12-9

DISCOVER
LEFLUNOMIDE FOR PEAK IDENTIFICATION CRS (1 MG)

LEFLUNOMIDE FOR PEAK IDENTIFICATION CRS (1 MG)

75706-12-6

DISCOVER
GEMCITABINE HYDROCHLORIDE CRS(60 MG)

GEMCITABINE HYDROCHLORIDE CRS(60 MG)

122111-03-9

DISCOVER
GEMCITABINE IMPURITY A CRS (25 MG)

GEMCITABINE IMPURITY A CRS (25 MG)

71-30-7

DISCOVER
BROMOCRIPTINE MESILATE FOR SYSTEM SUITABILITY CRS (5 MG)

BROMOCRIPTINE MESILATE FOR SYSTEM SUITABILITY CRS (5 MG)

22260-51-1

DISCOVER
ENALAPRILAT IMPURITY G CRS (0.005 MG)

ENALAPRILAT IMPURITY G CRS (0.005 MG)

NA

DISCOVER
Mepyramine impurity A CRS, 10mg

Mepyramine impurity A CRS, 10mg

NA

DISCOVER
MEPYRAMINE IMPURITY C CRS (15MG)

MEPYRAMINE IMPURITY C CRS (15MG)

504-29-0

DISCOVER